2013 Pharmaceutical Intellectual Property Forum (PIPF)

Key Topics

• Role of intellectual property in innovation and new product development
• Intellectual property in the pharmaceutical industry—navigating the regulatory landscape
• Brazil`s latest reforms in pharma patents and its implications for patent applications
• Pharmaceutical inventions in the us: hatch-waxman act and the orange book
• Ip strategies of multinational pharmaceutical enterprises
• Comparing patent regime of different countries
• Ip and the generics industry
• The impending patent cliff: implications for pharmaceutical companies
• Licensing & technology transfer strategies in the biotech & pharma industry
• Pharmaceutical patent prosecution and protection

Who should Attend

Attendees from:

• Biotech companies
• Pharmaceutical Companies
• Academic & Research Institutions
• Medical devices companies
• Intellectual Property Agencies
• Government Agencies
• Law firms